Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 211 to 225 of 1773 results for patient safety

  1. Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain (HTG491)

    Evidence-based recommendations on transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain in adults. This involves delivering focused ultrasound to a small part of the brain (in the thalamus) responsible for transmitting pain signals to destroy it.

    HealthTech guidance
    Published
    28 November 2018
    View recommendations

    Sections for HTG491

  2. Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (HTG646)

    Evidence-based recommendations on percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules. This involves using microwaves from a wire inserted into the nodule to heat and destroy it (ablation).

    HealthTech guidance
    Published
    16 November 2022
    View recommendations

    Sections for HTG646

  3. Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage (HTG587)

    Evidence-based recommendations on inducing and maintaining normothermia using temperature modulation devices after stroke or subarachnoid haemorrhage in adults. This involves cooling the body using pads placed on the skin or tubes put into the body.

    HealthTech guidance
    Published
    28 July 2021
    View recommendations

    Sections for HTG587

  4. Photodynamic endometrial ablation (HTG23)

    Evidence-based recommendations on photodynamic endometrial ablation. This involves using a light-sensitive chemical and laser to destroy the endometrium.

    HealthTech guidance
    Published
    24 March 2004
    View recommendations

    Sections for HTG23

  5. Endobronchial nerve ablation for chronic obstructive pulmonary disease (HTG604)

    Evidence-based recommendations endobronchial nerve ablation for chronic obstructive pulmonary disease. This involves destroying (ablating) the nerves on the outside of the airway (endobronchial nerves) to improve breathing.

    HealthTech guidance
    Published
    15 December 2021
    View recommendations

    Sections for HTG604

  6. Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder (HTG645)

    Evidence-based recommendations on extracorporeal shockwave therapy for calcific tendinopathy in the shoulder. This involves placing a device on the skin that delivers short pulses of sound into the shoulder. The aim is to reduce pain and improve shoulder function.

    HealthTech guidance
    Published
    9 November 2022
    View recommendations

    Sections for HTG645

  7. Radiofrequency ablation for palliation of painful spinal metastases (HTG669)

    Evidence-based recommendations on radiofrequency ablation for palliation of painful spinal metastases. This involves inserting a needle-like probe containing an electrode into the spinal metastases. This produces an electrical current that aims to relieve pain and other symptoms.

    HealthTech guidance
    Published
    5 April 2023
    View recommendations

    Sections for HTG669

  8. Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia (HTG639)

    Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves positioning a temporary implant in the urethra to increase the flow of urine.

    HealthTech guidance
    Published
    21 September 2022
    View recommendations

    Sections for HTG639

  9. Evidence on the safety and efficacy of endobronchial nerve ablation for chronic obstructive pulmonary disease (COPD) is inadequate in quantity. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page. Further research should be randomised controlled trials comparing the procedure with sham treatment. It should report details of patient selection, and short and long-term functional outcomes including lung functional outcomes, quality of life and patient-reported outcomes, incidence of exacerbations and hospital admissions, and all adverse events.

    Recommendation ID IPG174/01 Question Evidence on the safety and efficacy of endobronchial nerve ablation for chronic obstructive...

    Research recommendation
    Published
    7 January 2022

  10. Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)

    This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.

    Clinical guideline
    Last updated
    26 April 2023
    View recommendations

    Sections for CG104

  11. Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis (HTG558)

    Evidence-based recommendations on pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in adults. This involves spraying the inside of the peritoneal cavity with chemotherapy.

    HealthTech guidance
    Published
    28 October 2020
    View recommendations

    Sections for HTG558

  12. Subthalamotomy for Parkinson's disease (HTG38)

    Evidence-based recommendations on subthalamotomy for Parkinson's disease. This involves putting very thin needles into the brain through small holes made in the skull.

    HealthTech guidance
    Published
    23 June 2004
    View recommendations

    Sections for HTG38

  13. Interstitial photodynamic therapy for malignant parotid tumours (HTG166)

    Evidence-based recommendations on interstitial photodynamic therapy for malignant parotid tumours. This involves injecting a photosensitising agent into a vein and using a special light to activate it and destroy the tumour cells.

    HealthTech guidance
    Published
    23 April 2008
    View recommendations

    Sections for HTG166

  14. Platelet-rich plasma injections for knee osteoarthritis (HTG497)

    Evidence-based recommendations on platelet-rich plasma injections for knee osteoarthritis in adults. This involves taking plasma from a small amount of the person’s own blood and injecting it into the knee.

    HealthTech guidance
    Published
    23 January 2019
    View recommendations

    Sections for HTG497

  15. Evidence on the safety of transcranial magnetic stimulation for auditory hallucinations is adequate and raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. Find out  what only in research means on the NICE interventional procedures guidance page . Further research should be in the form of randomised controlled trials and should use well described treatment protocols. Studies should report details of patient selection including specific psychopathology, underlying disease and other treatments, the area of brain treated and the imaging used to target it, and long-term outcomes for at least 1 year.

    Evidence on the safety of transcranial magnetic stimulation for auditory hallucinations is adequate and raises no major...

    Research recommendation
    Published
    26 October 2020